Universe Pharmaceuticals INC SEC filings UPC
Universe Pharmaceuticals INC has 119 filings in SEC EDGAR's recent list, going back to Apr 24, 2020. Its latest annual report, Form 20-F, was filed on Jan 29, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| 424B4 | Prospectus | Jun 25, 2024 | — |
| F-1/A | Amendment no. 1 to form f-1 | May 14, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Apr 24, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 27, 2022 | — |
| 424B4 | Prospectus | Mar 24, 2021 | — |
| F-1/A | Amendment no. 4 to form f-1 | Mar 10, 2021 | — |
| FWP | Free writing prospectus | Mar 1, 2021 | — |
| FWP | Free writing prospectus | Mar 1, 2021 | — |
| F-1/A | Amendment no. 3 to form f-1 | Feb 24, 2021 | — |
| FWP | Free writing prospectus | Dec 10, 2020 | — |
| F-1/A | Amendment no.2 to form f-1 | Dec 2, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 17, 2020 | — |
| FWP | Free writing prospectus | Sep 23, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Aug 17, 2020 | — |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UPC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- China
- Headquarters
- Ji'An, Jiangxi, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1809616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.